The effect of TENS treatment on pain and mobility after Gamma nail hip fracture surgery

Effects of transcutaneous electrical nerve stimulation on acute postoperative pain intensity, ambulation and mobility after hip fracture: A double-blinded, randomized trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32476360

Enrollment

Registered

2018-07-30

Start date

2014-12-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracapsular proximal hip fracture stabilized with Gamma nail Injury, Occupational Diseases, Poisoning Extracapsular proximal hip/neck of femur fracture (intertrochanteric or subtrochanteric)

Interventions

Eligible subjects will be randomly allocated to one of two groups (active TENS or sham TENS) using a computer algorithm. Each group will receive the TENS treatment (active or sham) each morning for 5

however, this device will deliver no current. The participants in this group will be informed that not everyone will necessarily feel stimulation from the device. Participants in both

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Over 50 years of age 2. Stable extracapsular proximal hip fraction (intertrochanteric or subtrochanteric) 3. Partial or full weight bearing instructions 4. Ability to ambulate independently for at least 10 m with or without an assistive device prior to the fracture 5. Ability to follow instructions 6. Mini mental state test score = 20

Exclusion criteria

Exclusion criteria: 1. Conditions that contraindicate electrical stimulation (i.e. pacemakers, significant sensory loss in lower extremities, local wound at the site of electrode placement) 2. History of cardiovascular, neurological or orthopedic problems with a mobility limitation of walking less than 100 m 3. Prior experience with TENS 4. Infection or systemic disease that may interfere with the rehabilitation process (i.e. lupus disease)

Design outcomes

Primary

Measure	Time frame
Pain level at rest, at night and during ambulation, measured using a numeric rating scale (NRS) on days 1-5 before participants received TENS and physical therapy (PT) treatment Ambulation status measured using a functional ambulation classification (FAC) instrument on days 2-5 at the end of the training session, after the participants received TENS and PT treatment Physical performance tests - sit to stand (repeated five times) and two minute walk, assessed on the final day of treatment (day 5) after participants received TENS and PT treatment	—

Measure

Time frame

Pain level at rest, at night and during ambulation, measured using a numeric rating scale (NRS) on days 1-5 before participants received TENS and physical therapy (PT) treatment Ambulation status measured using a functional ambulation classification (FAC) instrument on days 2-5 at the end of the training session, after the participants received TENS and PT treatment Physical performance tests - sit to stand (repeated five times) and two minute walk, assessed on the final day of treatment (day 5) after participants received TENS and PT treatment

—

Countries

Israel

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 20, 2026